PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Fatigue is highly prevalent in pediatric inflammatory bowel disease (IBD), according to a study published in the January ...

A new study published March 30 in the European Heart Journal looked at links between vigorous exercise and the risk of ...

Prevention and screening are key when it comes to ulcerative colitis and its association with a slightly higher risk for ...

Royalty Pharma has inked a $500 million research-and-development co-funding agreement with Johnson & Johnson to support development of a proposed drug for autoimmune diseases. Royalty Pharma, a New ...

This medical group ensures patients are receiving today’s standard of care and tomorrow’s medical breakthroughs.

Learn ways to manage Crohn’s disease, one form of inflammatory bowel disease, a group of conditions that also includes ulcerative colitis.

Watch: The Crown Heights Crohn’s and Colitis Support group hosted Dr. Michael Dolinger for an evening dedicated to patients and caregivers living with the disease.

Valerie D’Angelo reclaimed her pup, a terrier-mix named Grace, on Wednesday after a Brooklyn Supreme Court ruling granted her ...

The human monoclonal antibody guselkumab has been approved for certain adults with moderately to severely active ulcerative ...

Ustekinumab dose intensification after loss of response in CD does not improve steroid-free remission at 48 weeks compared with standard dosing.